An observational study in End Stage Renal Disease, Pediatric ALL and Kidney Transplant; Complications, sponsored by Imagine Institute. Status unknown at 4 sites in France. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-08-04.
Sponsored by Imagine Institute · Observational
End-stage renal disease (ESRD) is a rare disease in children. Renal transplantation (RT) is the treatment of choice for ESRD in the pediatric population. In France, around 100 pediatric kidney transplants are performed each year. The aim was to evaluate the surgical management of TR and the long-term results.
End-stage renal disease (ESRD) is a rare pathology in children, whose gold standard treatment is a kidney transplant. In France, around 100 pediatric kidney transplants are performed every year.
Although the first adult kidney transplants were performed in 1954, pediatric renal transplantation was considered unsafe compared with dialysis, which was preferred. In the 1980s, improved graft selection, optimized pre-transplant management and a better understanding of the immune system led to the development of pediatric kidney transplantation.
Despite considerable progress, graft survival in these long-lived patients remains a major challenge.
The aim of this study is to evaluate surgical practices in the four French pediatric transplant centers, and to define risk factors for surgical complications.
2,121 studies on the registry are indexed under Kidney Failure, Chronic; 264 are open to participants now.
This study's planned enrollment of 500 is above the median of 120 across 441 observational studies indexed under Kidney Failure, Chronic.
Browse Kidney Failure, Chronic studies →Imagine Institute is the lead sponsor of 31 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients from 0 to 18 years who underwent renal transplant for ESRD
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Surgical outcomes
To assess surgical outcome in pediatric renal transplantation in terms of * per operative complications (ClassIntra classification) * post operative complications (Clavien Dindo) early \< 30 days and late \> 30 days
Time frame: 10 years
Surgical complications
Evaluate the surgical morbidity of renal transplantation
Time frame: 10 years
Graft Survival
Evaluate graft survival at 1, 5 and 10 years post transplantation
Time frame: 10 years
Return to dialysis
Evaluation of the need to return to dialysis after transplantation : causes and reasons
Time frame: 10 years
Retransplantation
Evaluation the number of patient undegoing another transplantation
Time frame: 10 years
Death
Evaluation of the morbidity of this population
Time frame: 10 years
Started Oct 2021 (actual). Primary completion is estimated for Jun 2024, 32 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Imagine Institute